支気管内超音波生検装置の世界市場レポート2026-2032

QY Research > レポート一覧 > 医療機器と消耗材 > 支気管内超音波生検装置の世界市場レポート2026-2032

英文タイトル： Global Endobronchial Ultrasound Biopsy Devices Market Outlook, In‑Depth Analysis & Forecast to 2032

レポートID：2091686
発表時期：2026-07-09
訪問回数：339
ページ数：136
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：144
レポートカテゴリ：医療機器と消耗材

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、支気管内超音波生検装置の世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別に支気管内超音波生検装置市場を分類しています。

本レポートでは、世界の支気管内超音波生検装置市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートは支気管内超音波生検装置の主要生産者を調査するとともに、主要地域や国の消費状況も提供します。支気管内超音波生検装置の主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Olympus
Boston Scientific
CONMED
Cook Medical
CLINODEVICE
Medtronic
MEDI-GLOBE
Broncus Medical
Creo Medical
Fujifilm
Micro Tech
AoHua
Jiuhong
Hobbs Medical

タイプ別市場セグメント：
Transbronchial Aspiration Needles
Biopsy Forceps
Biopsy Needles
Cytology Brushes
Spray Catheters
Others

用途別市場セグメント：
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Diagnostic Centers

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界の支気管内超音波生検装置市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて支気管内超音波生検装置市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）の支気管内超音波生検装置生産量、成長率、市場シェアを調査しています。
二. 消費面では、支気管内超音波生検装置の売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーの支気管内超音波生検装置売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界の支気管内超音波生検装置市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本支気管内超音波生検装置レポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：支気管内超音波生検装置レポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：支気管内超音波生検装置の世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：支気管内超音波生検装置の現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：支気管内超音波生検装置メーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：支気管内超音波生検装置の下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：支気管内超音波生検装置のグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米における支気管内超音波生検装置市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州における支気管内超音波生検装置市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域の支気管内超音波生検装置市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米における支気管内超音波生検装置市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域の支気管内超音波生検装置市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：支気管内超音波生検装置の主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：支気管内超音波生検装置のサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：支気管内超音波生検装置の市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Endobronchial Ultrasound Biopsy Devices market is projected to grow from US$ 643 million in 2025 to US$ 879 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications.

Endobronchial Ultrasound Biopsy Devices, as defined in this report under a consumables-only scope, refer to single-use or frequently consumed sampling instruments used through the working channel of an EBUS bronchoscope or bronchoscopy system to obtain tissue or cytology samples from the airway, mediastinum, hilar lymph nodes, and lesions adjacent to the tracheobronchial tree. Core products include EBUS-TBNA/FNA aspiration needles, EBUS-FNB biopsy needles, transbronchial aspiration needles, mini or conventional biopsy forceps, cytology brushes, spray catheters, and guide-assisted sampling accessories. Their clinical value lies in combining real-time ultrasound visualization with minimally invasive sampling, enabling physicians to support lung cancer diagnosis, mediastinal lymph node staging, cytology and histology testing, and sample acquisition for molecular diagnostics without open surgical access. As precision medicine, immunotherapy, and post-screening confirmation needs continue to expand, the product category is evolving from simply "obtaining a sample" to "obtaining sufficient, intact, and diagnostically valuable samples."

Endobronchial ultrasound biopsy consumables are high-value interventional endoscopy consumables, with an estimated overall gross margin generally in the range of 50%–75%. Premium EBUS-FNA/FNB needles and core tissue biopsy needles may reach approximately 60%–80%, driven by needle-tip engineering, flexibility, ultrasound visibility, puncture stability, sterile packaging, and regulatory requirements. Mature products such as conventional biopsy forceps, cytology brushes, and spray catheters usually have lower margins, broadly around 35%–60%, due to stronger competition and higher product standardization. Upstream inputs include medical-grade stainless steel, nitinol, PTFE/PEEK polymer tubing, handle components, sheaths, ultrasound-visible markers, and sterile packaging materials. Midstream activities cover precision tube processing, micro-device assembly, cleanroom manufacturing, sterilization validation, regulatory registration, and channel development. Downstream customers include respiratory intervention centers, oncology hospitals, thoracic surgery departments, endoscopy centers, and outpatient procedure facilities. The competitive core is not price alone, but puncture success, sample adequacy, compatibility with mainstream EBUS platforms, physician handling experience, product consistency, and clinical education capability.

Market Development Opportunities & Main Driving Factors
Lung cancer screening, wider use of low-dose CT, precision diagnosis, and molecular pathology are reshaping demand for respiratory intervention consumables. More pulmonary nodules and mediastinal lymph node lesions are being detected earlier, creating demand for safer, faster, and less invasive diagnostic pathways. EBUS-guided biopsy fits this clinical shift by enabling minimally invasive sampling in bronchoscopy suites or endoscopy centers, improving procedural efficiency and patient throughput. For manufacturers, the opportunity is not limited to volume expansion; it also lies in product upgrading, from standard aspiration needles to core biopsy needles, multiple gauge options, multi-platform compatibility, and sample-quality-oriented designs for molecular testing. With the development of domestic endoscopy platforms and respiratory intervention capacity, China, Asia-Pacific, and emerging markets are expected to become important sources of incremental growth.

Market Challenges, Risks, & Restraints
Although these products are classified as consumables, they enter deep airway and lymph node regions, requiring high standards for tip strength, flexibility, sheath smoothness, puncture stability, sterility assurance, and batch-to-batch consistency. Hospital purchasing decisions are influenced not only by price, but also by compatibility with mainstream EBUS platforms such as Olympus, Fujifilm, and Pentax, as well as physicians' established procedural habits. New entrants face long regulatory timelines, high clinical validation costs, slow hospital access, and significant investment in physician training. At the same time, reimbursement pressure, hospital price negotiations, and potential volume-based procurement may compress prices for mid- and low-end consumables. Conventional biopsy forceps and cytology brushes are more standardized and therefore more exposed to price competition. Without premium needle products, clinical evidence, and brand trust, low-price strategies alone are unlikely to create stable replacement in leading hospitals.

Downstream Demand Trends
Downstream demand is shifting from "performing a biopsy" to "high-quality sample acquisition for precision treatment decisions." Lung cancer care increasingly depends on histological subtyping, gene testing, PD-L1 testing, and other biomarker-driven decisions, raising expectations for sample volume, tissue integrity, and first-pass diagnostic yield. As a result, EBUS-FNB devices, core tissue biopsy needles, and intranodal sampling-enhancement consumables are expected to gain higher penetration. Hospitals are also pursuing shorter workflows, higher procedural turnover, and lower complication risk, which supports the adoption of standardized, traceable, single-use consumables. In the future, leading companies are likely to build integrated solutions around "EBUS platforms, premium sampling consumables, physician training, and pathology coordination," while specialized consumables manufacturers with stable production, regulatory capability, and clinical education strength may benefit from import substitution and regional market expansion.

Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Endobronchial Ultrasound Biopsy Devices market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Olympus
Boston Scientific
CONMED
Cook Medical
CLINODEVICE
Medtronic
MEDI-GLOBE
Broncus Medical
Creo Medical
Fujifilm
Micro Tech
AoHua
Jiuhong
Hobbs Medical

Segment by Type
Transbronchial Aspiration Needles
Biopsy Forceps
Biopsy Needles
Cytology Brushes
Spray Catheters
Others

Segment by Sampling Method
Needle Aspiration Sampling
Core Tissue Sampling
Forceps Biopsy
Cytology Brushing
Others

Segment by Clinical Application Site
Mediastinal and Hilar Lymph Node Sampling
Tracheobronchial Submucosal or Extramural Lesion Sampling
Endobronchial Visible Lesion Biopsy
Peripheral Pulmonary Lesion Sampling
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Diagnostic Centers

Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA

Chapter Outline
Chapter 1: Defines the Endobronchial Ultrasound Biopsy Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Endobronchial Ultrasound Biopsy Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Endobronchial Ultrasound Biopsy Devices Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Transbronchial Aspiration Needles
1.2.3 Biopsy Forceps
1.2.4 Biopsy Needles
1.2.5 Cytology Brushes
1.2.6 Spray Catheters
1.2.7 Others
1.3 Market Segmentation by Sampling Method
1.3.1 Global Endobronchial Ultrasound Biopsy Devices Market Size by Sampling Method, 2021 vs 2025 vs 2032
1.3.2 Needle Aspiration Sampling
1.3.3 Core Tissue Sampling
1.3.4 Forceps Biopsy
1.3.5 Cytology Brushing
1.3.6 Others
1.4 Market Segmentation by Clinical Application Site
1.4.1 Global Endobronchial Ultrasound Biopsy Devices Market Size by Clinical Application Site, 2021 vs 2025 vs 2032
1.4.2 Mediastinal and Hilar Lymph Node Sampling
1.4.3 Tracheobronchial Submucosal or Extramural Lesion Sampling
1.4.4 Endobronchial Visible Lesion Biopsy
1.4.5 Peripheral Pulmonary Lesion Sampling
1.4.6 Others
1.5 Market Segmentation by Application
1.5.1 Global Endobronchial Ultrasound Biopsy Devices Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.5.5 Diagnostic Centers
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Endobronchial Ultrasound Biopsy Devices Revenue Estimates and Forecasts (2021-2032)
2.2 Global Endobronchial Ultrasound Biopsy Devices Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape
3.1 Global Endobronchial Ultrasound Biopsy Devices Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Endobronchial Ultrasound Biopsy Devices Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Transbronchial Aspiration Needles: Market Share by Key Players
3.3.2 Biopsy Forceps: Market Share by Key Players
3.3.3 Biopsy Needles: Market Share by Key Players
3.3.4 Cytology Brushes: Market Share by Key Players
3.3.5 Spray Catheters: Market Share by Key Players
3.3.6 Others: Market Share by Key Players
3.4 Global Endobronchial Ultrasound Biopsy Devices Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation
4.1 Global Endobronchial Ultrasound Biopsy Devices Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Endobronchial Ultrasound Biopsy Devices Market by Sampling Method
4.2.1 Global Revenue by Sampling Method (2021-2032)
4.2.2 Global Revenue-Based Market Share by Sampling Method (2021-2032)
4.3 Global Endobronchial Ultrasound Biopsy Devices Market by Clinical Application Site
4.3.1 Global Revenue by Clinical Application Site (2021-2032)
4.3.2 Global Revenue-Based Market Share by Clinical Application Site (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Endobronchial Ultrasound Biopsy Devices Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application

6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Endobronchial Ultrasound Biopsy Devices Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Endobronchial Ultrasound Biopsy Devices Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico

7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Endobronchial Ultrasound Biopsy Devices Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Endobronchial Ultrasound Biopsy Devices Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia

8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Endobronchial Ultrasound Biopsy Devices Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Endobronchial Ultrasound Biopsy Devices Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore

9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Endobronchial Ultrasound Biopsy Devices Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Endobronchial Ultrasound Biopsy Devices Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Endobronchial Ultrasound Biopsy Devices Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Endobronchial Ultrasound Biopsy Devices Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Olympus
11.1.1 Olympus Corporation Information
11.1.2 Olympus Business Overview
11.1.3 Olympus Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.1.4 Olympus Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.1.5 Olympus Endobronchial Ultrasound Biopsy Devices Revenue by Product in 2025
11.1.6 Olympus Endobronchial Ultrasound Biopsy Devices Revenue by Application in 2025
11.1.7 Olympus Endobronchial Ultrasound Biopsy Devices Revenue by Geographic Area in 2025
11.1.8 Olympus Endobronchial Ultrasound Biopsy Devices SWOT Analysis
11.1.9 Olympus Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.2.4 Boston Scientific Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.2.5 Boston Scientific Endobronchial Ultrasound Biopsy Devices Revenue by Product in 2025
11.2.6 Boston Scientific Endobronchial Ultrasound Biopsy Devices Revenue by Application in 2025
11.2.7 Boston Scientific Endobronchial Ultrasound Biopsy Devices Revenue by Geographic Area in 2025
11.2.8 Boston Scientific Endobronchial Ultrasound Biopsy Devices SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 CONMED
11.3.1 CONMED Corporation Information
11.3.2 CONMED Business Overview
11.3.3 CONMED Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.3.4 CONMED Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.3.5 CONMED Endobronchial Ultrasound Biopsy Devices Revenue by Product in 2025
11.3.6 CONMED Endobronchial Ultrasound Biopsy Devices Revenue by Application in 2025
11.3.7 CONMED Endobronchial Ultrasound Biopsy Devices Revenue by Geographic Area in 2025
11.3.8 CONMED Endobronchial Ultrasound Biopsy Devices SWOT Analysis
11.3.9 CONMED Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Corporation Information
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.4.4 Cook Medical Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.4.5 Cook Medical Endobronchial Ultrasound Biopsy Devices Revenue by Product in 2025
11.4.6 Cook Medical Endobronchial Ultrasound Biopsy Devices Revenue by Application in 2025
11.4.7 Cook Medical Endobronchial Ultrasound Biopsy Devices Revenue by Geographic Area in 2025
11.4.8 Cook Medical Endobronchial Ultrasound Biopsy Devices SWOT Analysis
11.4.9 Cook Medical Recent Developments
11.5 CLINODEVICE
11.5.1 CLINODEVICE Corporation Information
11.5.2 CLINODEVICE Business Overview
11.5.3 CLINODEVICE Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.5.4 CLINODEVICE Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.5.5 CLINODEVICE Endobronchial Ultrasound Biopsy Devices Revenue by Product in 2025
11.5.6 CLINODEVICE Endobronchial Ultrasound Biopsy Devices Revenue by Application in 2025
11.5.7 CLINODEVICE Endobronchial Ultrasound Biopsy Devices Revenue by Geographic Area in 2025
11.5.8 CLINODEVICE Endobronchial Ultrasound Biopsy Devices SWOT Analysis
11.5.9 CLINODEVICE Recent Developments
11.6 Medtronic
11.6.1 Medtronic Corporation Information
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.6.4 Medtronic Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.6.5 Medtronic Recent Developments
11.7 MEDI-GLOBE
11.7.1 MEDI-GLOBE Corporation Information
11.7.2 MEDI-GLOBE Business Overview
11.7.3 MEDI-GLOBE Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.7.4 MEDI-GLOBE Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.7.5 MEDI-GLOBE Recent Developments
11.8 Broncus Medical
11.8.1 Broncus Medical Corporation Information
11.8.2 Broncus Medical Business Overview
11.8.3 Broncus Medical Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.8.4 Broncus Medical Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.8.5 Broncus Medical Recent Developments
11.9 Creo Medical
11.9.1 Creo Medical Corporation Information
11.9.2 Creo Medical Business Overview
11.9.3 Creo Medical Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.9.4 Creo Medical Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.9.5 Creo Medical Recent Developments
11.10 Fujifilm
11.10.1 Fujifilm Corporation Information
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.10.4 Fujifilm Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Micro Tech
11.11.1 Micro Tech Corporation Information
11.11.2 Micro Tech Business Overview
11.11.3 Micro Tech Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.11.4 Micro Tech Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.11.5 Micro Tech Recent Developments
11.12 AoHua
11.12.1 AoHua Corporation Information
11.12.2 AoHua Business Overview
11.12.3 AoHua Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.12.4 AoHua Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.12.5 AoHua Recent Developments
11.13 Jiuhong
11.13.1 Jiuhong Corporation Information
11.13.2 Jiuhong Business Overview
11.13.3 Jiuhong Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.13.4 Jiuhong Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.13.5 Jiuhong Recent Developments
11.14 Hobbs Medical
11.14.1 Hobbs Medical Corporation Information
11.14.2 Hobbs Medical Business Overview
11.14.3 Hobbs Medical Endobronchial Ultrasound Biopsy Devices Product Features and Attributes
11.14.4 Hobbs Medical Endobronchial Ultrasound Biopsy Devices Revenue and Gross Margin (2021-2026)
11.14.5 Hobbs Medical Recent Developments

12 Endobronchial Ultrasound Biopsy Devices Value Chain and Ecosystem Analysis
12.1 Endobronchial Ultrasound Biopsy Devices Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Endobronchial Ultrasound Biopsy Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Endobronchial Ultrasound Biopsy Devices Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Table 2. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Sampling Method, 2021 vs 2025 vs 2032 (US$ Million)
 Table 3. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Clinical Application Site, 2021 vs 2025 vs 2032 (US$ Million)
 Table 4. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Table 5. Global Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 6. Global Endobronchial Ultrasound Biopsy Devices Revenue by Region (US$ Million), 2021-2026
 Table 7. Global Endobronchial Ultrasound Biopsy Devices Revenue by Region (US$ Million), 2027-2032
 Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 9. Global Endobronchial Ultrasound Biopsy Devices Revenue by Players (US$ Million), 2021-2026
 Table 10. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Players (2021-2026)
 Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
 Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Endobronchial Ultrasound Biopsy Devices Revenue, 2025
 Table 13. Global Endobronchial Ultrasound Biopsy Devices Average Gross Margin (%) by Player (2021 vs 2025)
 Table 14. Global Endobronchial Ultrasound Biopsy Devices Companies Headquarters
 Table 15. Global Endobronchial Ultrasound Biopsy Devices Market Concentration Ratio (CR5)
 Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
 Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 18. Global Endobronchial Ultrasound Biopsy Devices Revenue by Type (US$ Million), 2021-2026
 Table 19. Global Endobronchial Ultrasound Biopsy Devices Revenue by Type (US$ Million), 2027-2032
 Table 20. Global Endobronchial Ultrasound Biopsy Devices Revenue by Sampling Method (US$ Million), 2021-2026
 Table 21. Global Endobronchial Ultrasound Biopsy Devices Revenue by Sampling Method (US$ Million), 2027-2032
 Table 22. Global Endobronchial Ultrasound Biopsy Devices Revenue by Clinical Application Site (US$ Million), 2021-2026
 Table 23. Global Endobronchial Ultrasound Biopsy Devices Revenue by Clinical Application Site (US$ Million), 2027-2032
 Table 24. Key Product Attributes and Differentiation
 Table 25. Global Endobronchial Ultrasound Biopsy Devices Revenue by Application (US$ Million), 2021-2026
 Table 26. Global Endobronchial Ultrasound Biopsy Devices Revenue by Application (US$ Million), 2027-2032
 Table 27. Endobronchial Ultrasound Biopsy Devices High-Growth Sectors Demand CAGR (2026-2032)
 Table 28. Top Customers by Region
 Table 29. Top Customers by Application
 Table 30. North America Endobronchial Ultrasound Biopsy Devices Growth Accelerators and Market Barriers
 Table 31. North America Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 32. Europe Endobronchial Ultrasound Biopsy Devices Growth Accelerators and Market Barriers
 Table 33. Europe Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 34. Asia-Pacific Endobronchial Ultrasound Biopsy Devices Growth Accelerators and Market Barriers
 Table 35. Asia-Pacific Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Central and South America Endobronchial Ultrasound Biopsy Devices Investment Opportunities and Key Challenges
 Table 37. Central and South America Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 38. Middle East and Africa Endobronchial Ultrasound Biopsy Devices Investment Opportunities and Key Challenges
 Table 39. Middle East and Africa Endobronchial Ultrasound Biopsy Devices Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 40. Olympus Corporation Information
 Table 41. Olympus Description and Major Businesses
 Table 42. Olympus Product Features and Attributes
 Table 43. Olympus Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 44. Olympus Revenue Proportion by Product in 2025
 Table 45. Olympus Revenue Proportion by Application in 2025
 Table 46. Olympus Revenue Proportion by Geographic Area in 2025
 Table 47. Olympus Endobronchial Ultrasound Biopsy Devices SWOT Analysis
 Table 48. Olympus Recent Developments
 Table 49. Boston Scientific Corporation Information
 Table 50. Boston Scientific Description and Major Businesses
 Table 51. Boston Scientific Product Features and Attributes
 Table 52. Boston Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 53. Boston Scientific Revenue Proportion by Product in 2025
 Table 54. Boston Scientific Revenue Proportion by Application in 2025
 Table 55. Boston Scientific Revenue Proportion by Geographic Area in 2025
 Table 56. Boston Scientific Endobronchial Ultrasound Biopsy Devices SWOT Analysis
 Table 57. Boston Scientific Recent Developments
 Table 58. CONMED Corporation Information
 Table 59. CONMED Description and Major Businesses
 Table 60. CONMED Product Features and Attributes
 Table 61. CONMED Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 62. CONMED Revenue Proportion by Product in 2025
 Table 63. CONMED Revenue Proportion by Application in 2025
 Table 64. CONMED Revenue Proportion by Geographic Area in 2025
 Table 65. CONMED Endobronchial Ultrasound Biopsy Devices SWOT Analysis
 Table 66. CONMED Recent Developments
 Table 67. Cook Medical Corporation Information
 Table 68. Cook Medical Description and Major Businesses
 Table 69. Cook Medical Product Features and Attributes
 Table 70. Cook Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 71. Cook Medical Revenue Proportion by Product in 2025
 Table 72. Cook Medical Revenue Proportion by Application in 2025
 Table 73. Cook Medical Revenue Proportion by Geographic Area in 2025
 Table 74. Cook Medical Endobronchial Ultrasound Biopsy Devices SWOT Analysis
 Table 75. Cook Medical Recent Developments
 Table 76. CLINODEVICE Corporation Information
 Table 77. CLINODEVICE Description and Major Businesses
 Table 78. CLINODEVICE Product Features and Attributes
 Table 79. CLINODEVICE Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 80. CLINODEVICE Revenue Proportion by Product in 2025
 Table 81. CLINODEVICE Revenue Proportion by Application in 2025
 Table 82. CLINODEVICE Revenue Proportion by Geographic Area in 2025
 Table 83. CLINODEVICE Endobronchial Ultrasound Biopsy Devices SWOT Analysis
 Table 84. CLINODEVICE Recent Developments
 Table 85. Medtronic Corporation Information
 Table 86. Medtronic Description and Major Businesses
 Table 87. Medtronic Product Features and Attributes
 Table 88. Medtronic Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 89. Medtronic Recent Developments
 Table 90. MEDI-GLOBE Corporation Information
 Table 91. MEDI-GLOBE Description and Major Businesses
 Table 92. MEDI-GLOBE Product Features and Attributes
 Table 93. MEDI-GLOBE Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 94. MEDI-GLOBE Recent Developments
 Table 95. Broncus Medical Corporation Information
 Table 96. Broncus Medical Description and Major Businesses
 Table 97. Broncus Medical Product Features and Attributes
 Table 98. Broncus Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 99. Broncus Medical Recent Developments
 Table 100. Creo Medical Corporation Information
 Table 101. Creo Medical Description and Major Businesses
 Table 102. Creo Medical Product Features and Attributes
 Table 103. Creo Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 104. Creo Medical Recent Developments
 Table 105. Fujifilm Corporation Information
 Table 106. Fujifilm Description and Major Businesses
 Table 107. Fujifilm Product Features and Attributes
 Table 108. Fujifilm Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 109. Fujifilm Recent Developments
 Table 110. Micro Tech Corporation Information
 Table 111. Micro Tech Description and Major Businesses
 Table 112. Micro Tech Product Features and Attributes
 Table 113. Micro Tech Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 114. Micro Tech Recent Developments
 Table 115. AoHua Corporation Information
 Table 116. AoHua Description and Major Businesses
 Table 117. AoHua Product Features and Attributes
 Table 118. AoHua Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 119. AoHua Recent Developments
 Table 120. Jiuhong Corporation Information
 Table 121. Jiuhong Description and Major Businesses
 Table 122. Jiuhong Product Features and Attributes
 Table 123. Jiuhong Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 124. Jiuhong Recent Developments
 Table 125. Hobbs Medical Corporation Information
 Table 126. Hobbs Medical Description and Major Businesses
 Table 127. Hobbs Medical Product Features and Attributes
 Table 128. Hobbs Medical Revenue (US$ Million) and Gross Margin (2021-2026)
 Table 129. Hobbs Medical Recent Developments
 Table 130. Technologies, Platforms and Infrastructure
 Table 131. Distributors List
 Table 132. Market Trends and Market Evolution
 Table 133. Market Drivers and Opportunities
 Table 134. Market Challenges, Risks, and Restraints
 Table 135. Research Programs/Design for This Report
 Table 136. Key Data Information from Secondary Sources
 Table 137. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 2. Transbronchial Aspiration Needles Product Picture
 Figure 3. Biopsy Forceps Product Picture
 Figure 4. Biopsy Needles Product Picture
 Figure 5. Cytology Brushes Product Picture
 Figure 6. Spray Catheters Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Sampling Method, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 9. Needle Aspiration Sampling Product Picture
 Figure 10. Core Tissue Sampling Product Picture
 Figure 11. Forceps Biopsy Product Picture
 Figure 12. Cytology Brushing Product Picture
 Figure 13. Others Product Picture
 Figure 14. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Clinical Application Site, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 15. Mediastinal and Hilar Lymph Node Sampling Product Picture
 Figure 16. Tracheobronchial Submucosal or Extramural Lesion Sampling Product Picture
 Figure 17. Endobronchial Visible Lesion Biopsy Product Picture
 Figure 18. Peripheral Pulmonary Lesion Sampling Product Picture
 Figure 19. Others Product Picture
 Figure 20. Global Endobronchial Ultrasound Biopsy Devices Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 21. Hospitals
 Figure 22. Ambulatory Surgical Centers
 Figure 23. Specialty Clinics
 Figure 24. Diagnostic Centers
 Figure 25. Endobronchial Ultrasound Biopsy Devices Report Years Considered
 Figure 26. Global Endobronchial Ultrasound Biopsy Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 27. Global Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 28. Global Endobronchial Ultrasound Biopsy Devices Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 29. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Region (2021-2032)
 Figure 30. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share Ranking (2025)
 Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
 Figure 32. Transbronchial Aspiration Needles Revenue-Based Market Share by Player in 2025
 Figure 33. Biopsy Forceps Revenue-Based Market Share by Player in 2025
 Figure 34. Biopsy Needles Revenue-Based Market Share by Player in 2025
 Figure 35. Cytology Brushes Revenue-Based Market Share by Player in 2025
 Figure 36. Spray Catheters Revenue-Based Market Share by Player in 2025
 Figure 37. Others Revenue-Based Market Share by Player in 2025
 Figure 38. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Type (2021-2032)
 Figure 39. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Sampling Method (2021-2032)
 Figure 40. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Clinical Application Site (2021-2032)
 Figure 41. Global Endobronchial Ultrasound Biopsy Devices Revenue-Based Market Share by Application (2021-2032)
 Figure 42. North America Endobronchial Ultrasound Biopsy Devices Revenue YoY (US$ Million), 2021-2032
 Figure 43. North America Top 5 Players Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) in 2025
 Figure 44. North America Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) by Application (2021-2032)
 Figure 45. US Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 46. Canada Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 47. Mexico Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 48. Europe Endobronchial Ultrasound Biopsy Devices Revenue YoY (US$ Million), 2021-2032
 Figure 49. Europe Top 5 Players Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) in 2025
 Figure 50. Europe Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) by Application (2021-2032)
 Figure 51. Germany Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 52. France Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 53. U.K. Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 54. Italy Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 55. Russia Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 56. Asia-Pacific Endobronchial Ultrasound Biopsy Devices Revenue YoY (US$ Million), 2021-2032
 Figure 57. Asia-Pacific Top 8 Players Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) in 2025
 Figure 58. Asia-Pacific Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) by Application (2021-2032)
 Figure 59. Indonesia Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 60. Japan Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 61. South Korea Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 62. Australia Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 63. India Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 64. Indonesia Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 65. Vietnam Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 66. Malaysia Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 67. Philippines Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 68. Singapore Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 69. Central and South America Endobronchial Ultrasound Biopsy Devices Revenue YoY (US$ Million), 2021-2032
 Figure 70. Central and South America Top 5 Players Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) in 2025
 Figure 71. Central and South America Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) by Application (2021-2032)
 Figure 72. Brazil Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 73. Argentina Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 74. Middle East and Africa Endobronchial Ultrasound Biopsy Devices Revenue YoY (US$ Million), 2021-2032
 Figure 75. Middle East and Africa Top 5 Players Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) in 2025
 Figure 76. Middle East and Africa Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million) by Application (2021-2032)
 Figure 77. GCC Countries Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 78. Israel Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 79. Egypt Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 80. South Africa Endobronchial Ultrasound Biopsy Devices Revenue (US$ Million), 2021-2032
 Figure 81. Endobronchial Ultrasound Biopsy Devices Value Chain Mapping
 Figure 82. Channels of Distribution (Direct Vs Distribution)
 Figure 83. Bottom-up and Top-down Approaches for This Report
 Figure 84. Data Triangulation
 Figure 85. Key Executives Interviewed

以下、関連資料のご紹介